Independent quantitative risk analysis of Injective. Updated March 2026.
EXERCISE CAUTION
Injective has a moderate risk profile with a Ba1 rating. Research thoroughly before investing.
49.2
Trust Score
Ba1
Rating
33%
Crash Risk
WARNING
Alert Level
Is Injective a Scam?
Based on ZARQ's quantitative analysis, Injective shows 1 structural weakness signal. Active structural weaknesses require careful monitoring. The Distance-to-Default stands at 2.7, indicating moderate — some structural pressure.
Frequently Asked Questions
Is Injective safe to buy?
Injective (INJECTIVE) has a ZARQ Trust Score of 49.2/100 and a Ba1 rating. The crash probability is 33%. Verdict: exercise caution.
Is Injective a scam?
Based on quantitative analysis, Injective shows 1 structural weakness signal. The alert level is WARNING. A trust score of 49.2/100 suggests elevated risk — conduct thorough research.
What is the crash risk for Injective?
ZARQ estimates a 33% probability of a >50% drawdown. The Distance-to-Default is 2.7.
Should I invest in Injective?
This is not financial advice. Injective has a Ba1 rating (49.2/100). It falls below investment-grade criteria. Always do your own research.
Disclaimer: ZARQ ratings are quantitative risk assessments, not investment advice. Always conduct your own research. Past performance does not predict future results.